Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.
about
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsyDuloxetine: a review of its use in the management of major depressive disorder in older adults.Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation.Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.Where is the room for improvement in the drug treatment of depression and anxiety?
P2860
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Clinical outcome and tolerabil ...... week study with plasma levels.
@en
Clinical outcome and tolerabil ...... week study with plasma levels.
@nl
type
label
Clinical outcome and tolerabil ...... week study with plasma levels.
@en
Clinical outcome and tolerabil ...... week study with plasma levels.
@nl
prefLabel
Clinical outcome and tolerabil ...... week study with plasma levels.
@en
Clinical outcome and tolerabil ...... week study with plasma levels.
@nl
P2093
P2860
P356
P1476
Clinical outcome and tolerabil ...... -week study with plasma levels
@en
P2093
A Fiorentini
C Mencacci
I F De Gaspari
L S Volonteri
P2860
P304
P356
10.1177/0269881109104863
P407
P577
2009-04-30T00:00:00Z